<DOC>
	<DOC>NCT00171262</DOC>
	<brief_summary>To analyze efficacy of fluvastatin on patients with chronic renal disease by analyzing certain inflammatory markers. In addition, tolerability and safety will also be evaluated in a Spanish population.</brief_summary>
	<brief_title>Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Patients &gt; 18 years Patients that give their inform consent Pregnant women Diabetic patients Treated with statins for the year prior to study inclusion Patients with contraindications listed in fluvastatin prescribing information Other protocoldefined in and exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dyslipidemia, chronic renal disease, fluvastatin</keyword>
</DOC>